155 related articles for article (PubMed ID: 7820140)
21. Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection.
Beck SD; Foster RS; Bihrle R; Koch MO; Wahle GR; Donohue JP
J Urol; 2001 May; 165(5):1517-20. PubMed ID: 11342909
[TBL] [Abstract][Full Text] [Related]
22. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis.
Heidenreich A; Thüer D; Polyakov S
Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770
[TBL] [Abstract][Full Text] [Related]
23. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma.
Rabbani F; Farivar-Mohseni H; Leon A; Motzer RJ; Bosl GJ; Sheinfeld J
Urology; 2003 Dec; 62(6):1092-6. PubMed ID: 14665362
[TBL] [Abstract][Full Text] [Related]
25. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
Hartmann JT; Candelaria M; Kuczyk MA; Schmoll HJ; Bokemeyer C
Eur J Cancer; 1997 May; 33(6):843-7. PubMed ID: 9291803
[TBL] [Abstract][Full Text] [Related]
26. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
[TBL] [Abstract][Full Text] [Related]
27. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
[TBL] [Abstract][Full Text] [Related]
28. [Clinical study of retroperitoneal lymph node dissection for patients with advanced germ cell tumors].
Okamura K; Yuba H; Nishimura T; Mizutani K; Takashi M; Gotoh M; Ono Y; Ohshima S
Hinyokika Kiyo; 1999 Feb; 45(2):95-101. PubMed ID: 10212781
[TBL] [Abstract][Full Text] [Related]
29. The role of retroperitoneal lymph node dissection in the management of testicular cancer.
Stephenson AJ; Sheinfeld J
Urol Oncol; 2004; 22(3):225-33; discussion 234-5. PubMed ID: 15271322
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of postchemotherapy retroperitoneal lymph node dissection following high-dose chemotherapy with stem cell transplantation.
Cary C; Pedrosa JA; Jacob J; Beck SD; Rice KR; Einhorn LH; Foster RS
Cancer; 2015 Dec; 121(24):4369-75. PubMed ID: 26371446
[TBL] [Abstract][Full Text] [Related]
31. Primary chemotherapy: how does it compare with surgery?
Horwich A
Semin Urol Oncol; 1996 Feb; 14(1):34-5. PubMed ID: 8833387
[TBL] [Abstract][Full Text] [Related]
32. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.
Ondrus D; Hornák M; Breza J; Mat'oska J; Schnorrer M; Belan V; Kausitz J
Int Urol Nephrol; 2001; 32(4):665-7. PubMed ID: 11989561
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.
Brenner PC; Herr HW; Morse MJ; Sheinfeld J; Aprikian A; Bosl GJ; Motzer RJ; Bajorin DF; Schantz S; Fair WR; Burt M
J Clin Oncol; 1996 Jun; 14(6):1765-9. PubMed ID: 8656244
[TBL] [Abstract][Full Text] [Related]
34. RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment.
Weissbach L; Bussar-Maatz R; Flechtner H; Pichlmeier U; Hartmann M; Keller L
Eur Urol; 2000 May; 37(5):582-94. PubMed ID: 10765098
[TBL] [Abstract][Full Text] [Related]
35. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience.
Steiner H; Peschel R; Janetschek G; Höltl L; Berger AP; Bartsch G; Hobisch A
Urology; 2004 Mar; 63(3):550-5. PubMed ID: 15028456
[TBL] [Abstract][Full Text] [Related]
36. Resection of residual masses alone: an alternative in surgical therapy of metastatic testicular germ cell tumors after chemotherapy.
Ozen H; Ekici S; Sozen S; Ergen A; Tekgül S; Kendi S
Urology; 2001 Feb; 57(2):323-7. PubMed ID: 11182346
[TBL] [Abstract][Full Text] [Related]
37. Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.
Steyerberg EW; Donohue JP; Gerl A; Toner GC; Schraffordt Koops H; Fosså SD; Keizer HJ
J Urol; 1997 Aug; 158(2):474-8. PubMed ID: 9224327
[TBL] [Abstract][Full Text] [Related]
38. Peri-operative care in patients treated for testicular cancer.
Donat SM
Semin Surg Oncol; 1999 Dec; 17(4):282-8. PubMed ID: 10588858
[TBL] [Abstract][Full Text] [Related]
39. Pathological findings after primary chemotherapy in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection for advanced germ cell tumours.
Miller RE; Dudderidge T; Huddart R; Seckl MJ; Rustin GJ; Christmas TJ
BJU Int; 2013 Apr; 111(4 Pt B):E152-7. PubMed ID: 23016566
[TBL] [Abstract][Full Text] [Related]
40. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003].
Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N
Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
